Chunyi Hao

27PUBLICATIONS
47CO-AUTHORS
Cancer diagnosisHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 24, 2026
Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025).

|Dec 24, 2024
Prognostic Value of N1/N2 Neutrophils Heterogeneity and Tertiary Lymphoid Structure in Hepatocellular Carcinoma Patients.

Yanfei Lang, Weiwei Fu, Wei Xu

|Sep 16, 2024
Advancing treatment efficacy: combined therapy of eribulin, anlotinib, and camrelizumab in advanced or metastatic retroperitoneal liposarcoma.

Weiwei Jia, Jianhui Wu, Hongtao Zhang

|Aug 29, 2024
Implication of Capillary Morphogenesis Gene 2 (CMG2) in the Disease Progression and Peritoneal Metastasis of Pancreatic Cancer.

Ziqian Fang, Carly Bunston, Yali Xu

|Aug 19, 2024
Prognostic Nutritional Index (PNI): A More Promising Nutritional Predictor for Patients Undergoing Surgery for Retroperitoneal Liposarcoma.

Guo-Qiang Xue, Cheng-Peng Li, Ang Lv

|Aug 08, 2024
Combination of eribulin and anlotinib exerts synergistic cytotoxicity in retroperitoneal liposarcoma by inducing endoplasmic reticulum stress.

Shuquan Li, Hongtao Zhang, Hao Yu

Pageof 5

Frequent Collaborators

3 joint publications

Jianhui Wu

2 joint publications

Dao-Ning Liu

2 joint publications

Xiuyun Tian

1 joint publications

Zhong-Wu Li